01/21/2014
New Orleans—Patients with heavily pretreated, relapsed chronic lymphocytic leukemia (CLL) not suitable for chemotherapy had a significant increase in progression-free survival, overall survival, and overall response rate if they received...
New Orleans—Patients with heavily pretreated, relapsed chronic lymphocytic leukemia (CLL) not suitable for chemotherapy had a significant increase in progression-free survival, overall survival, and overall response rate if they received...
New Orleans—Patients with...
01/21/2014
First Report Managed Care